These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
741 related articles for article (PubMed ID: 29487020)
1. [Factors associated with the severity of acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa]. Saka B; Dzidzinyo K; Akakpo S; Téclessou J; Nouhou Diori A; Maneh N; Mahamadou G; Gnassingbé W; Abilogun-Chokki A; Mouhari-Toure A; Boubacar YA; Kombaté K; Balo K; Tchangai-Walla K; Pitché P Ann Dermatol Venereol; 2018 Apr; 145(4):245-249. PubMed ID: 29487020 [TBL] [Abstract][Full Text] [Related]
2. [Ophthalmic manifestations after Lyell and Stevens-Johnson syndromes]. Mouafik SB; Hocar O; Akhdari N; Amal S; Belghmaidi S; Ennassiri W; Hajji I; Moutaouakil A Ann Dermatol Venereol; 2015; 142(6-7):393-8. PubMed ID: 25896732 [TBL] [Abstract][Full Text] [Related]
3. Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa: a multicentric study in four countries. Saka B; Barro-Traoré F; Atadokpédé FA; Kobangue L; Niamba PA; Adégbidi H; Yedomon HG; Traoré A; Pitché VP Int J Dermatol; 2013 May; 52(5):575-9. PubMed ID: 23330601 [TBL] [Abstract][Full Text] [Related]
4. [Stevens-Johnson syndrome and toxic epidermal necrolysis in a teaching hospital in Lomé, Togo: retrospective study of 89 cases]. Saka B; Kombaté K; Mouhari-Toure A; Akakpo S; Tchangaï-Walla K; Pitché P Med Trop (Mars); 2010 Jun; 70(3):255-8. PubMed ID: 20734593 [TBL] [Abstract][Full Text] [Related]
5. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN. Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study. Chow LLW; Shih KC; Chan JCY; Lai JSM; Ng ALK BMC Ophthalmol; 2017 May; 17(1):65. PubMed ID: 28499410 [TBL] [Abstract][Full Text] [Related]
7. Stevens-Johnson and Lyell syndromes in children in a hospital setting in Lomé, Togo, from 2000 to 2015. Akakpo AB; Saka B; Abilogoun-Chokki AE; Teclessou JN; Mahamadou G; Gnassingbe W; Mouhari-Toure A; Kombate K; Pitche P Med Sante Trop; 2018 May; 28(2):332-333. PubMed ID: 29976535 [TBL] [Abstract][Full Text] [Related]
8. Predictive Factors Associated With Acute Ocular Involvement in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Sotozono C; Ueta M; Nakatani E; Kitami A; Watanabe H; Sueki H; Iijima M; Aihara M; Ikezawa Z; Aihara Y; Kano Y; Shiohara T; Tohyama M; Shirakata Y; Kaneda H; Fukushima M; Kinoshita S; Hashimoto K; Am J Ophthalmol; 2015 Aug; 160(2):228-237.e2. PubMed ID: 25979679 [TBL] [Abstract][Full Text] [Related]
9. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis. Gueudry J; Roujeau JC; Binaghi M; Soubrane G; Muraine M Arch Dermatol; 2009 Feb; 145(2):157-62. PubMed ID: 19221260 [TBL] [Abstract][Full Text] [Related]
10. Ocular and Mucocutaneous Sequelae among Survivors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Togo. Saka B; Akakpo AS; Teclessou JN; Mahamadou G; Mouhari-Toure A; Dzidzinyo K; Diori AN; Maneh N; Prince-Agbodjan S; Kombaté K; Balo K; Tchangai-Walla K; Pitché P Dermatol Res Pract; 2019; 2019():4917024. PubMed ID: 30838038 [TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome. Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483 [TBL] [Abstract][Full Text] [Related]
12. Ocular manifestations in patients with Stevens-Johnson syndrome in Malawi-review of the literature illustrated by clinical cases. Schulze Schwering M; Kayange P; Rothe C Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2343-2348. PubMed ID: 31352606 [TBL] [Abstract][Full Text] [Related]
13. Relationship between Atopic Disease and Acute Ocular and Systemic Outcomes in Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Kwan J; Ahmed H; Ponsetto MK; Succar T; Chodosh J; Saeed HN Ocul Immunol Inflamm; 2023 Jul; 31(5):900-904. PubMed ID: 35486647 [TBL] [Abstract][Full Text] [Related]
14. The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy. De Rojas MV; Dart JK; Saw VP Br J Ophthalmol; 2007 Aug; 91(8):1048-53. PubMed ID: 17314145 [TBL] [Abstract][Full Text] [Related]
15. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475 [TBL] [Abstract][Full Text] [Related]
16. Genitourinary involvement and management in children with Stevens-Johnson syndrome and toxic epidermal necrolysis. Van Batavia JP; Chu DI; Long CJ; Jen M; Canning DA; Weiss DA J Pediatr Urol; 2017 Oct; 13(5):490.e1-490.e7. PubMed ID: 28314701 [TBL] [Abstract][Full Text] [Related]
17. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience. Forman R; Koren G; Shear NH Drug Saf; 2002; 25(13):965-72. PubMed ID: 12381216 [TBL] [Abstract][Full Text] [Related]